This message was sent to ##Email##
ASHI would like to extend a warm Thank You to the labs that participated in the ASHI PT Program this year. We also want to thank all the labs that have submitted their lists of user information in preparation for the upcoming 2018 PT year.
If your lab plans to participate in our 2018 PT program and has not submitted a list of lab users for the 2018 year, please contact ASHI PT Coordinator, Cheryl Hartman at email@example.com at your earliest convenience.
2018 Ordering: We understand that many labs are eager to place their PT order for the 2018 year and we are just as eager to provide the opportunity to do so. The ordering system is very close to completion and we greatly appreciate your patience as the last few details are finalized. PT ordering for 2018 will be available very soon! Stay tuned for more information.
Did you know you can manage your ASHI email notifications? Here's how!
Go to the ASHI website and log-in with your username and password. Under My Profile click on Manage Profile, then click on Preferences under the heading Information & Settings.
On this screen, you can select or deselect the notifications you wish to receive in your email. At the bottom, remember to click on Save my Settings when you are done before exiting the page.
Just a few more weeks left to renew your 2018 ASHI membership in order to avoid disruption of your ASHI benefits.
Your membership dues allow us to provide programs, professional awards, and educational opportunities that advance the science, education and application of immunogenetics and transplant immunology. Click here to renew today!
- New wallchart with an overview of the HLA molecule, genes and nomenclature: REQUEST WALLCHART
- Still using lymphocyte separation medium (LSM)? Isolate cells from whole blood without centrifugation or lysis: WATCH VIDEO
- This case study shows how cell purity affects flow cytometry crossmatch (FCXM) results: READ CASE STUDY
- RoboSep™-16 can isolate cells from up to 16 samples simultaneously:
- Purity assessment by flow cytometry for lineage-specific chimerism analysis: READ MORE
The ASHI Career Center will help ensure your recruitment advertising efforts attract the hard-to-reach candidates you seek. Here's how...
Ready to find the perfect candidate? Click here to get started!
- Posting jobs to a niche site like the ASHI Career Center provides your ad exposure to highly qualified professionals instead of the unqualified masses.
- Upgrading your job listings to ensure they appear high on search results drives significantly more views, clicks and applies.
- Supplementing job postings with banner ads can help build your brand as a desirable employer and attract the best candidates.
Name & Credentials: Cindy Sue Raven, BS, MT(ASCP), CHS(ABHI)
Job Title: Director of Laboratories and Component Preparation
Place of employment: Michigan Blood, Part of Versiti
Graduated from: Michigan State University
How long have you been an ASHI member? 38 years
When did you attend your first ASHI meeting? I believe my first meeting was in Pittsburg. I have a lot of special memories. My favorite memory is of Paul Terasaki asking if he could share my table at breakfast, I believe at the Washington DC conference.
We'd love to feature you in the Member Spotlight section of an upcoming issue of ASHI Insights! Just complete this online form.
SAVE THE DATE!
Check back often for more information about the 2018 ASHI Regional Education Workshops.
|ASHI REGIONAL EDUCATION WORKSHOP 1:
Bally's Las Vegas
3645 S. Las Vegas Blvd.
Las Vegas, NV
April 12-14, 2018
|ASHI REGIONAL EDUCATION WORKSHOP 2:|
Hilton Garden Inn Cleveland Downtown
1100 Carnegie Ave.
June 28-30, 2018
Medical Laboratory Professionals Week is April 22 – 28, 2018. How will your lab celebrate? Click here to see ASHI's collection of pictures from the 2017 Lab Week celebration.
Have you posted your response to the latest question on the Online Tech Forum? It's not too late to join the discussion regarding a technologist salary survey! Click here to read more!
In June 2015, the OPTN/UNOS Board of Directors approved a rewrite of the histocompatibility bylaws that included the general supervisor to the list of laboratory key personnel. The implementation of the addition of this new requirement was delayed to allow for the development of a new key personnel application form, which then needed approval by the Office of Management and Budget (OMB). The OMB has recently approved the new general supervisor key personnel application form.
As part of the implementation of this bylaw, UNOS will send the OPTN general supervisor key personnel application to all OPTN approved histocompatibility laboratories. All approved histocompatibility laboratories will be asked to complete and submit the general supervisor key personnel application form within 30 days.
The effective date of the general supervisor key personnel requirement bylaw will coincide with the date that the Membership and Professional Standards Committee acts on all of the general supervisor applications received during the 30 day submission period. All OPTN approved histocompatibility laboratories will need to submit this form within the 30 day period to remain in compliance with the histocompatibility laboratory membership requirements. If UNOS
receives the application after the deadline, UNOS cannot guarantee that it will be processed prior to the implementation date. The new bylaw language can be found in the Histocompatibility Bylaws Rewrite Phase II policy notice on the OPTN website. If you have any questions, please contact Christi Manner, Jasmine Smith or Tierra Simpkins by phone at (804) 782-4800 or by email using the format firstname.lastname@example.org.
VxMatch now features full LIMS integration, MFI cut-offs and custom visualizations. VxMatch is a dedicated application that displays DSA trends, dilution and reactivity history and has been validated at leading HLA labs. Click here to schedule a full demo or view our recent ASHI poster on VxMatch to learn more.
The Travel Fund Award was created to help new ASHI members attend regional and annual meetings. The ASHI Board of Directors has approved two grants for Technologist members for each Regional meeting in 2018. For the Annual meeting, two grants have been reserved for Technologist members and two for Doctoral level members.
2017 Travel Award Recipient Tim Girouard of Massachusetts General Hospital says:
"I found the annual meeting to be excellent this past year. Some of the highlights for me were the antibody assessment abstract session, case study workshop, the technologist forum and the First Star workshop update. I also found the inspector's workshop extremely informative. I wish I attended this workshop at previous meetings.
Here at MGH, education and travel money is at a premium, as I'm sure it is at other centers. The travel fund helped offset my out of pocket cost to allow me to attend. While I value the education obtained at this meeting, the real benefit was networking with other tissue-typers. It was extremely valuable to be able to chat with other professionals about their workflows, assays, struggles and successes."
ASHI is able to continue its mission because of your support and generosity. By contributing to the travel fund award, you'll help us give more opportunities to members like Tim Girouard.
Online donations are quick and easy using our secure credit card transactions. We welcome donations of all sizes and payment plans – whether it's a one-time gift, a monthly contribution or part of a matching gifts program. Donate today by clicking here!
Your lab could win up to $1,000 in funding to host an HLA meeting! ASHI has prepared all the tools you need to organize your local meeting including an ASHI Local Meeting Handbook. Ready to get started? Just submit an application for funding. Applications are reviewed on an ongoing basis.
ASHI will sponsor two joint symposia at FOCIS 2018 - one with the American Society of Transplantation and The Transplantation Society and the other with The Association of Medical Laboratory Immunologists. FOCIS is the meeting in translational immunology that will give you a competitive edge in your career. Stay ahead of the curve with leading clinicians and researchers delivering the latest breakthroughs across immune-mediated diseases. Focusing on molecular pathways and their implications in human disease provides the unique opportunity for innovative thinking and application of ideas from the pathologies of other diseases to uncover novel solutions to challenges in the diseases you study. For more information, click here.
Did you miss the professional photos from the 2017 ASHI Annual Meeting in San Francisco? Click here to start viewing them. Feel free to save them, share them and post them to your social media using the hashtag #ASHIAnnual2017.
Mark your calendar now for future ASHI Annual Meetings!
44TH ANNUAL MEETING
October 1-5, 2018
Baltimore Marriott Waterfront
45TH ANNUAL MEETING
September 23-27, 2019
David L. Lawrence Convention Center
46TH ANNUAL MEETING
October 19-23, 2020
The alloreactivity of natural killer (NK) cell after allogeneic hematopoietic stem cell transplantation (AHSCT) is regulated by the interaction between donor killer immunoglobulin-like receptors (KIRs) and recipient human leukocyte antigen (HLA)-class I molecules.
The single antigen test is widely used in the field of transplantation to determine the specificity of HLA antibodies. It will be beneficial to standardize the procedure of the single antigen test among HLA laboratories. It is not uncommon that single antigen testing on native sera fails to detect antibodies with very high concentrations.
Homozygous carriers of CCR5-Δ32, a gene variant of CC-type chemokine receptor 5 (CCR5), are highly resistant to infections with human immunodeficiency virus type 1 (HIV-1) and therefore preferred stem cell donors for HIV-infected patients. We analyzed CCR5 typing data of 1,333,035 potential hematopoietic stem cell donors enlisted with three national DKMS donor centers.
50 Minthorn Blvd.Suite 800, Thornhill, Ontario L3T 7X8